A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ENOX / enoxaparin

[Related PubMed/MEDLINE]
Total Number of Papers: 30
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ENOX  (>> Co-occurring Abbreviation)
Long Form:   enoxaparin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2023 Biological Properties of Heparins Modified with an Arylazopyrazole-Based Photoswitch. DS, PS, UFH
2022 Low Prevalence of Thrombosis Prophylaxis Dose Adjustments Highlights Implications for Patient Safety. BMI, PTP, TBW, UFH, VTE
2022 Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors. DTX, SEDDS
2021 Enoxaparin prevents CXCL16/ADAM10-mediated cisplatin renal toxicity: Role of the coagulation system and the transcriptional factor NF-kappaB. CBC, CD3, CP, CXCL16, NF-kappaB, PT, TF, TNF-alpha
2020 A Novel Turn on Fluorescence Sensor for Determination Enoxaparin, a Low Molecular Weight Heparin. FL, LMWH
2020 Comparison of low-molecular-weight heparins in thromboprophylaxis of major orthopaedic surgery - randomized, prospective pilot study. Dalt, THR, TKR
2018 Enoxaparin does not affect network formation of adipose tissue-derived microvascular fragments. ad-MVF, GFP, LMWH
2018 The Efficacy and Safety of Enoxaparin: A Meta-analysis. MI, PCI, RCTs, STEMI, UFH
2017 Passive targeting and lung tolerability of enoxaparin microspheres for a sustained antithrombotic activity in rats. MP
10  2017 Polysaccharides-based nanocomplexes for the prolonged delivery of enoxaparin: In-vitro and in-vivo evaluation. CS, DS, NCs
11  2015 Anticoagulant properties of enoxaparin 400IU/mL-40% ethanol catheter lock solution. ETP, UFH
12  2012 Mesenteric ischemia-reperfusion injury: clearly improved hemodynamics but only minor protection of the rat small intestine by (sub)therapeutic heparin sodium and enoxaparin doses. HepSo, SMAO
13  2011 Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial. abx, ASSENT-3
14  2010 Enoxaparin treatment administered at both early and late stages of amyloid beta deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Abeta levels. ---
15  2010 Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry. AMI, STEMI, UFH
16  2008 Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. GP, UFH
17  2007 A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study. STEMI, STRes, UFH
18  2007 Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel. CI, MACE, STEMI, UFH
19  2007 Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25. RR, UFH
20  2007 Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. PCI, STEMI, UFH
21  2007 The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. CrCl, STEMI, UFH
22  2007 [The safety of enoxaparine use in elderly with acute myocardial infarction]. AMI, UFH
23  2005 Early postoperative use of unfractionated heparin or enoxaparin is associated with increased surgical re-exploration for bleeding. UFH
24  2004 Accelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study). ASK, CR, SK, STEMI
25  2003 Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting. CABG, UFH
26  2003 Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. UFH
27  2003 Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab. ABC, PCI, UFH
28  2003 ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction. ABCX, UH
29  2002 Head-to-head comparison of two different low-molecular-weight heparins in acute coronary syndrome: a single center experience. Dalt, LMWH, NQMI, s.c, UA
30  1998 The low molecular weight heparin, enoxaparin, limits infarct size at reperfusion in the dog. Hep, SK